Open original FDA record ↗Recall record
- FDA identifier
- Z-0249-2022
- Company in FDA record
- Fujifilm Irvine Scientific, Inc.
- FDA record creation date
- Nov 17, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to a component in kit being labeled with the incorrect Expiration Date
Source facts
- Action
- On September 09, 2021, the firm, Fujifilm, sent Customer notification letter via e-mail to customers (direct) and Distributors under heading "Notice: Product Labeling Information", notifying customers of the components in a kit may be labeled with an incorrect expiration date. The firm determined that the product is safe to use, however, customer to follow the expiration date on the kit label and of Certificate Of Analysis, which had shorter expiration date than the affected products expiration date. Two product types had incorrect expiration date. The customer data collection form sent to the customer of the actions to be taken by customer/end user to fill out and send the acknowledgement form if they had affected products or did not have affected products and the quantity consumed or remained in inventory and mail the acknowledgement via e-mail. The firm revised the Customer Notification letter as "Urgent: Medical Device Correction-Supplemental Information" with the Placard to customers via USPS and informed Distributors to send Notification to their customers. The customers will be asked to: - follow the expiration date on the product kit label and Certificate of Analysis - check their inventory for affected product - inform their staff of the contents of the Notification letter - place the Placard near their affected inventory - contact the firm if they prefer to return and/or replace their affected inventory. The firm provided contact information as: fisira@fujifilm.com 24/7, or by phone at 1 (949) 261-7800 The firm asked their customers in revised data collection form and added Product Information, to notify the firm on # of kits received, # of kits consumed and # of kits remaining in inventory. The Quality Assurance placed the affected lots on "cease distribution" until the firm completes an investigation.
- Initiated
- 2021-09-08
- Root cause
- Software design
- Distribution
- Worldwide Distribution: U.S. (nationwide) to states of: AL, AK, AZ, CA, CT, DE, FL, ID, IL, IN, ND, NC, NV, NY, NJ, NE, OH, OK, OR, PA, SC, SD, MA, MS, MI, MO, MD, MN, TN, TX, UT, VA, VT, WI, WV and OUS (international) to countries of: Brazil, EU, Canada, India, South Korea, and Singapore.
- Recall number
- Z-0249-2022
- Recall status
- Open, Classified
- CDRH record ID
- 189398
- FDA record created
- 2021-11-17
- Recall event number
- 88720